An innovative treatment for debilitating and often deadly cases of recurrent C diff infection has been given a Breakthrough Therapy Designation by the FDA. Developed by US biotech firm Rebiotix ...
After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes.
Bristol-Myers Squibb's late stage hepatitis C product has been designated a Breakthrough Therapy Designation by the FDA. The company's investigational DCV Dual Regimen (daclatasvir and asunaprevir ...
GlobalData on MSN5d
FDA breakthrough status for Bluejay’s CHD therapy brelovitugThe US FDA has granted breakthrough therapy designation to Bluejay Therapeutics’ brelovitug, to treat chronic hepatitis delta ...
(RTTNews) - GSK plc (GSK, GSK.L) said that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for GSK5764227, its B7-H3-targeted antibody-drug conjugate (ADC ...
In 2024, PF614-MPAR received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA), and had its development bolstered by a $14 million multi-year award from the ...
Please provide your email address to receive an email when new articles are posted on . The FDA has granted breakthrough therapy designation to Bluejay Therapeutics’ brelovitug for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback